BREAKING NEWS

U.S. health regulator approves Teva's migraine drug

By REUTERS

SEPTEMBER 15, 2018 01:29

Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes.

The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.

Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.

NATO allies will need to spend closer to 3% of GDP on defense

By REUTERS

11/25/2024 12:24 PM

Children in Safed find Mandate-era grenade, sappers called to the scene

By ELI ASHKENAZI

11/25/2024 11:53 AM

Rocket fired from northern Gaza falls in open area

By JERUSALEM POST STAFF

11/25/2024 11:52 AM

Ukraine's air force says it downed 71 drones during Russia's attack

By REUTERS

11/25/2024 11:45 AM